BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,099,000 | +3.8% | 7,268 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $1,059,000 | +22.9% | 7,268 | 0.0% | 0.01% | +50.0% |
Q1 2022 | $862,000 | -14.0% | 7,268 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,002,000 | -0.8% | 7,268 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,010,000 | +43.1% | 7,268 | 0.0% | 0.00% | +33.3% |
Q2 2021 | $706,000 | +42.1% | 7,268 | 0.0% | 0.00% | +50.0% |
Q1 2021 | $497,000 | -20.2% | 7,268 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $623,000 | +32.0% | 7,268 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $472,000 | -11.1% | 7,268 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $531,000 | +115.0% | 7,268 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $247,000 | -32.0% | 7,268 | +8.9% | 0.00% | 0.0% |
Q4 2019 | $363,000 | +30.1% | 6,676 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $279,000 | -4.5% | 6,676 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $292,000 | – | 6,676 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |